BC

Birchview Capital Portfolio holdings

AUM $101M
This Quarter Return
-4.06%
1 Year Return
+34.62%
3 Year Return
+103.2%
5 Year Return
+107.72%
10 Year Return
+352.1%
AUM
$128M
AUM Growth
+$128M
Cap. Flow
-$2.3M
Cap. Flow %
-1.8%
Top 10 Hldgs %
76.57%
Holding
60
New
3
Increased
5
Reduced
1
Closed
5

Top Buys

1
TVTX icon
Travere Therapeutics
TVTX
$675K
2
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
$347K
3
BLUE
bluebird bio
BLUE
$322K
4
PGNY icon
Progyny
PGNY
$289K
5
ELUT icon
Elutia
ELUT
$211K

Top Sells

1
ALBO
Albireo Pharma, Inc. Common Stock
ALBO
$2.53M
2
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
$1.5M
3
ATEC icon
Alphatec Holdings
ATEC
$156K
4
CNCE
Concert Pharmaceuticals, Inc.
CNCE
$117K
5
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$102K

Sector Composition

1 Healthcare 96.37%
2 Energy 3.59%
3 Consumer Staples 0.04%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ETRN
26
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
$769K 0.6%
133,050
– –
TVTX icon
27
Travere Therapeutics
TVTX
$1.62B
$675K 0.53%
+30,000
New +$675K
BLUE
28
DELISTED
bluebird bio
BLUE
$633K 0.5%
199,200
+101,200
+103% +$322K
TSVT
29
DELISTED
2seventy bio
TSVT
$610K 0.48%
59,833
– –
ISEE
30
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$608K 0.48%
25,000
– –
IMGN
31
DELISTED
Immunogen Inc
IMGN
$576K 0.45%
150,000
– –
TXG icon
32
10x Genomics
TXG
$1.65B
$558K 0.44%
10,000
– –
SLNO icon
33
Soleno Therapeutics
SLNO
$3.61B
$525K 0.41%
245,127
– –
ARVN icon
34
Arvinas
ARVN
$562M
$410K 0.32%
15,000
– –
SILK
35
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$391K 0.31%
10,000
– –
HALO icon
36
Halozyme
HALO
$8.69B
$382K 0.3%
10,000
– –
XENE icon
37
Xenon Pharmaceuticals
XENE
$3.01B
$358K 0.28%
10,000
– –
KDNY
38
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$347K 0.27%
+15,000
New +$347K
SRPT icon
39
Sarepta Therapeutics
SRPT
$1.79B
$345K 0.27%
2,500
– –
XNCR icon
40
Xencor
XNCR
$610M
$343K 0.27%
12,300
– –
KNSA icon
41
Kiniksa Pharmaceuticals
KNSA
$2.54B
$323K 0.25%
30,000
– –
KALV icon
42
KalVista Pharmaceuticals
KALV
$715M
$314K 0.25%
40,000
– –
FOLD icon
43
Amicus Therapeutics
FOLD
$2.39B
$311K 0.24%
28,000
– –
KROS icon
44
Keros Therapeutics
KROS
$634M
$299K 0.23%
7,000
– –
PGNY icon
45
Progyny
PGNY
$2.01B
$289K 0.23%
+9,000
New +$289K
CGEM icon
46
Cullinan Oncology
CGEM
$453M
$257K 0.2%
25,114
– –
BCRX icon
47
BioCryst Pharmaceuticals
BCRX
$1.75B
$167K 0.13%
20,000
– –
IFRX icon
48
InflaRx
IFRX
$115M
$136K 0.11%
70,000
– –
GOSS icon
49
Gossamer Bio
GOSS
$598M
$125K 0.1%
99,088
– –
STOK icon
50
Stoke Therapeutics
STOK
$1.1B
$125K 0.1%
15,000
– –
1
2
3